Mr. Cohen is a seasoned medical device, pharmaceutical and biotechnology executive with a series of positions leading organizations with full P&L responsibility, and previous departmental management experience in virtually all functional areas, including international sales, R&D, healthcare services, M&A, corporate marketing, legal affairs and business & technology development, coupled with strategic oversight and planning positions.
He most recently was President & CEO of EmboMedics, Inc., an early stage medical device company developing resorbable, drug-loadable embolic spheres to treat, among other things, liver cancer. In two years, Mr. Cohen reorganized and recapitalized the Company, redirected product development to advance quickly to FDA submission, and then sold EmboMedics to a larger medical device company. Prior to that, he founded Miromatrix Medical, an early stage biotechnology device company with a patent-protected technology that enables the construction of fully biological human organs for transplant, and grew the enterprise to a $90+ million valuation over seven years by technology development, creating and commercializing two products, extensive partnering and business development activities, regulatory and reimbursement success, and $31 million in fundraising.
Before Miromatrix, Mr. Cohen built significant shareholder value as President & CEO of Travanti Pharma Inc. through technology, product and business development, followed by the successful sale of the company to Teikoku Pharma five years after his arrival. Mr. Cohen has held senior management positions with both large organizations (Pfizer Inc.; Sulzermedica; St. Jude Medical) and small enterprises (Miromatrix Medical; Travanti Pharma; Advanced Circulatory Systems [sold to ZOLL Medical]; Horizon Medical Products [public offering]; GCI Medical), as well as seven Board of Directors positions. Diverse activities have included successfully taking a company public on the NYSE in a billion dollar offering, initiating and developing new products through to market, establishing a manufacturing facility in a foreign tax-friendly environment, a series of acquisitions, divestitures and licensing transactions ranging from several thousand dollars to almost one billion dollars, raising capital for early stage companies, and restructuring sales activities in Japan. Mr. Cohen is able to leverage more than thirty-five years of clinical, distribution, executive, venture capital and investment banking relationships.
Outside of his efforts on behalf of Zomedica, Mr. Cohen’s primary passion is his two boys and their families. Although his playing days are over, he is a big baseball fan, as well as an avid music enthusiast. There were years of playing and coaching baseball in his past, as well as playing in and managing bands and writing original music. His favorite animal is Duke, a beautiful and loving Golden Retriever.
Dr. Morley leads Zomedica’s veterinary and innovation strategies, and facilitates new business opportunities to ensure the delivery of high quality veterinary products by aligning customer needs, translational technologies, and corporate objectives.
Dr. Morley is a trained veterinarian with instinctive business acumen. Over the course of her 15 year career, she has become known as a transformational leader, experienced in building viable business units and overseeing departments with 600 plus staff and annual budgets totaling $40 million in operating expenses. After earning a Bachelor of Arts in hospitality and a Doctor of Veterinary Medicine degree from Michigan State University. Dr. Morley practiced veterinary medicine at Oakwood Animal Hospital in Kalamazoo, MI and Adobe Animal Medical Center in Albuquerque, NM where she learned to juggle the roles of clinical practitioner and operations manager.
During her tenure with MPI Research, she was rapidly promoted, advancing from lower-level supervisory roles to Vice President of Operations by building rapport across functions to instill a culture of collaboration. As Associate Director of Business Development with the University of Michigan Medical School, Dr. Morley bridged communications between faculty members and external industry partners, translating science to business and business to science, in efforts to fast track innovations from discovery insight to market impact.
When she is not building the business, Dr. Morley can be found downhill skiing or tackling home improvement projects alongside her husband and their five children. Her personal tenet is to have fun in all endeavors and be the best example possible to her family, friends, community and professional network that are part of her journey.
Ann has primary responsibility for planning, implementation, and management of Zomedica’s finance activities, including business planning, budgeting, forecasting and negotiations. She served as the Company’s Vice President of Finance from August 2018 until October 2020, when she was promoted to her current role.
Throughout her career, Ann has held various consulting, controllership and Chief Financial Officer roles for both private and publicly held companies and has public accounting experience in both audit and tax services. She served as Chief Financial Officer of American Fence Company, a fence rental, installation and manufacturing company, from April 2018 through August 2018. She has also served as Corporate Controller of ProMotion Technology Group, a digital solutions provider, from September 2014 through August 2017. Ann holds a Master of Taxation from Capital University Law School and a Bachelor of Arts in Economics and Spanish from Capital University. She is a Certified Public Accountant, licensed in Ohio since 1996.
Bruk joined the executive team in January 2017 and is responsible for leading sales, marketing, and customer support to execute the company’s commercial strategy and deliver results, including the launch of products currently in development.
Known as a highly accomplished and forward-thinking leader, Bruk excels in unifying teams to achieve common goals and deliver best-in-class products and services that positively impact both the customer experience and animal health. With over 20 years of experience and an acute understanding of the animal health market, he has honed his ability to achieve accelerated revenue growth, lasting customer relationships, and industry-leading results. Over the course of his dynamic career, he has successfully launched numerous veterinary products on behalf of global corporations and startup enterprises.
Prior to joining Zomedica, Bruk was Executive Senior Vice President of Sales and Marketing at i4C Innovations. Before that, he served as Executive Senior Director and Head of U.S. Sales at IDEXX Laboratories, where he was responsible for in-clinic and reference lab diagnostics, point of care solutions, information technologies, and digital radiography solutions. He has also held sales leadership roles in patient monitoring, pharmacy and diagnostics with Omnicare Specialty Care Group and Life Systems. Bruk holds a Bachelor of Science in business from the University of Arizona.
Outside of his quest for operational excellence and team building, Bruk enjoys spending time with his family, including his two daughters, one son, and dog, Mochi.
©2021 Zomedica Corp. and Zomedica Inc. All rights reserved.
Zomedica and the Zomedica logo are registered trademarks of Zomedica Inc.
TRUFORMA is a registered trademark of Zomedica Corp.
